Background/Aims: Gastric subepithelial tumor (SET) is often noted incidentally during esophagogastroduodenoscopy (EGD). The prevalence of SET is increasing in accordance with the increase of EGD and endosonographies. SET can range from benign lesions to tumors with malignant behavior or potential such as gastrointestinal stromal tumor (GIST) and carcinoid tumor. The aim of this study was to evaluate clinical features and risk factors of gastric SET that needed surgery in a single center.
INTRODUCTION

Gastric subepithelial tumor (SET) is often noted under the performance of esophagogastroduodenoscopy (EGD).
Although it is often called as submucosal tumor (SMT), it is not appropriate terminology. The prevalence of SET is progressively higher, according to increase of conduct of EGD and endosonography (endoscopic ultrasonography, EUS). In Korea, SET diagnoses are especially increasing as an increasing number of individuals undergo EGD for general medical examinations. SET is often incidentally found without clinical symptoms and signs. Accurate diagnosis is very difficult because specimen is not obtained by conventional methods of biopsy. EUS has an important role in the diagnosis and the evaluation of SET.
Particularly, EUS-guided fine needle aspiration biopsy (EUS-FNAB) or trucut biopsy has been shown to be useful in confirming the pathologic diagnosis and proposing a therapeutic strategy. [1] [2] [3] [4] SET can range from benign lesions to tumors with malignant behavior or potential to become malignant such as gastrointestinal stromal tumor (GIST) and carcinoid tumor. The objective of this study was to evaluate the clinical features and significant risk factors of gastric SET needed surgery in a single center.
MATERIALS AND METHODS
Between January 2006 and December 2010, a total of 90 patients with SET in the stomach underwent surgical operations at Yeungnam University Hospital. We retrospectively analyzed the medical records of all the enrolled patients including EGD figures, EUS figures, and pathologic findings. We defined the gastric SET as a subepithelial lesion in the stomach. The EGD findings such as 
RESULTS
The mean age of enrolled 90 patients was 56.8±13.4 years. Female patients were predominant (60%). The ratio of gender was 2:3 (male:female). The mean size of gastric SET was 33.3±29.1 mm. Baseline characteristics of the enrolled patients are shown in Table 1 . Of 90 patients, the patients diagnosed as GIST, ectopic pancreas, leiomyoma, schwannoma, carcinoid tumor, and inflammatory fibroid polyp after surgery were 43 (47.8%), 14 (15.6%), 13 (14.4%), 8 (8.9%), 3 (3.3%), and 2 (2.2%), respectively. The remaining seven cases were adenomyoma, eosinophilic abscess, angiodysplasia, and so on. Of 90 patients, 79 (87.8%) patients checked preoperative abdominal CT. There was only one case which showed distant metastasis in abdominal CT. The most common location of SET was the body of stomach (36.6%). The SET with mucosal ulceration were in only 7 cases (7.8%). The preoperative EUS was performed on 71 (78.9%) patients. The most common origin layer of SET was muscularis propria layer or fourth layer of the stomach in EUS study (81%). The median follow-up duration was 51.5 weeks (Table 1 ). In addition, clinical and endoscopic features according to histopathologic results were shown in Table 2 . Size and location of gastric SET were significantly different among histopathologic results (P =0.003, P =0.004).
All enrolled patients were divided into and non-malignant vs. malignant group and non-GIST vs. GIST group. Among the baseline characteristics of the patients, the non-malignant and malignant group were significantly different in age of patients, and size of gastric SET, respectively (P =0.007, P =0.029, Table 3 ). Furthermore, the differences of baseline characteristics of the non-GIST group and the GIST group were also statistically significant in age of patient, and size of gastric SET, respectively (P =0.004, P =0.011, Table 4 ). At multivariate analysis for detection of independent risk factors of malignant gastric SET, age of patient was an independent risk factor by binary logistic regression analysis (OR, 1.045; 95% CI, 1.008∼1.084; P =0.016). Likewise, according to binary logistic regression analysis, independent risk factors of gastric SET with potential of GIST were age of patient 
Values are presented as n (%) or mean±SD. GIST, gastrointestinal stromal tumor. Values are presented as n (%) or mean±SD. Values are presented as n (%) or mean±SD. GIST, gastrointestinal stromal tumor. (OR, 1.049; 95% CI, 1.011∼1.089; P =0.011), and size of gastric SET (OR, 1.026; 95% CI, 1.002∼1.050; P =0.031) (Table 5 ). According to age of patient and size of tumor as independent risk factors of gastric SET with malignant potential, subgroup analysis was performed. The patients were divided into subgroups by measurement of five years in age from 45 years to 70 years, because the range of age in the enrolled patients was 18∼88 years, and a quartile patients' age and third quartile patients' age was 48.0 years, and 67.3 years, respectively. Likewise, the patients were divided into subgroups by measurement of 5 mm in size from 15 mm to 40 mm, because the range of size in gastric SET was 4∼150 mm, and the size of a quartile SET and third quartile SET was 18.8 mm, and 40.0 mm, respectively. Multiple logistic regression analysis Values are presented as n (%) or mean±SD. GIST, gastrointestinal stromal tumor; HPF, high power field. (Table 6) . A total of 43 cases which were diagnosed as GIST were subjected to a precision analysis. The mean mitotic index over 50 high power field (HPF) in the GIST was 4.5 (median: 3.0, SD: 5.2). The cell types of the GIST were reported to be spindle cell type, epithelioid cell type, and mixed cell type, accounting for 38 (88.4%), 2 (2.2%), and 1 (1.1%), respectively. The mean size of the GIST was 41.7±36.6 mm. According to the pathologic risk assessment of the GIST, the percentage of patients with none, very low, low, moderate, and high risk were 27.9% (12/43), 41.9% (18/43), 7% (3/43), 9.3% (4/43), 14% (6/43), respectively (Table 7) . 5 Considering the pathologic risk assessments of GIST, there were no significant differences among the origin layer, cell types, and mucosal ulceration of the GIST (P ＞0.05). The mean size of the carcinoid tumors was 12.0±7.0 mm. In only one case of three carcinoid tumors, preoperative EUS and abdominal CT were conducted. The related symptoms and sign of patients with gastric SET needed surgical intervention were subclinical (52.2%), epigastric discomfort or pain (33.3%), bleeding (3.3%), enlarged size (3.3%), dyspepsia (3.3%), and discomfort with dyspepsia (2.2%), respectively. The remaining two other causes were the increase of 18 F-fluoro-2-deoxyglucose uptake in PET (n=1) and abdominal bloating (n=1).
DISCUSSION
A bulging mucosa or subepithelial mass encountered during EGD has increased along with the increased use of EGD. These masses are commonly referred to as SMT, but they are more appropriately termed as subepithelial lesion because they may arise from any layer of the gastric wall (intramural) or from extrinsic compression of structures outside of the wall (extramural). 6 A conventional EGD cannot diagnose an SET accurately. Therefore, EUS is increasingly used to differentiate between intramural and extramural lesion, confirm the origin layer of SET, and estimate its exact size.
On large-sized SET (≥3 cm), EUS is generally conducted and followed up regularly. However, in the cases of small SET, many endoscopists are prone to overlook them and not to follow up. Some reports showed that small SET (＜1 cm) might only need a regular endoscopic follow-up. 7 In contrast, small SET may be clinically important because some subepithelial lesions are malignant or have malignant potential. 8 Also, surgical intervention is often needed due to bleeding unrelated to the size of SET. Therefore, further evaluation and management plans are necessary for the proper treatment of an incidentally found SET. For this reason, we aimed to assess the clinical features and risk factors of SET needed a surgical interevention. A total of 90 patients with SET in stomach have undergone operation during the four years. GIST was the most common pathologic diagnosis (47.8%) of SET which underwent operation. Carcinoid tumors with malignant potential were in only three cases (3.3%). There were no clinical symptoms and signs in about half of the operated patients (52.2%). Only three patients were operated due to the increase of tumor size through EUS. The enlarged SETs were diagnosed as gastritis cystica profunda, schwannoma, and GIST, respectively. Some studies reported that the increase of the size of an SET indicated a GIST. 9 Nevertheless, GIST was in only one of the above cases in our study. The three cases operated due to bleeding were all diagnosed as GISTs. In this study, the relationship between SET and EUS could not be evaluated correctly, because more than 20 percents of the operated patients did not undergo preoperative EUS. At analysis of some gastric SET for which EUS was conducted, layer of origin and hyperechogenicity were not statistically significant with malignant gastric SET (P =0.264, P =0.743). However, this analysis is incomplete, complete EUS survey for gastric SET should be conducted.
The majority of GIST are benign, only 20% being malignant. 10 Fletcher et al. 11 reported that the pathologic risk assessment of GIST was connected to the size of tumor and the mitotic index of over 50 HPF. The site, size, origin layer, ulceration and necrosis, except mitotic index of over 50 HPF, were not statistically significant risk of GIST in our study. According to our results, high mitotic index of GIST should be considered in determining surgical interventions regardless of the size of GIST. The methods which are used to diagnose GIST and assess the risks, in advance, utilize EUS and EUS-FNAB as a stepwise approach. 7, 12 EUS is recommended for an SE T＞1 cm in diameter, EUS-FNAB is recommended for an SET with hypoechogenicity＜3 cm in diameter, and a surgery is recommended for an SET＞3 cm in diameter. 13 However, these recommendations cannot be absolute. Some studies reported that small GIST (＜2 cm) had a very low malignant potential11 and large sized GIST (＞3 cm) had high risks.
14 But other studies showed that GIST had malignancy when the SET were small but hypoechoic and had the 3rd and the 4th layers of gastric wall just like those in this study. 15 The optimal management of gastric SET remains controversial, because the natural history of GIST remains incompletely defined. Physicians should decide if EUS or EUS-FNAB is needed or available based on their experiences and patients' conditions. In our study, old age or large size should be considered as a determining factor for conducting EUS or EUS-FNAB to detect malignant gastric SET. Especially, according to subgroup analysis, age≥60 years and size≥25 mm in gastric SET were independent risk factors for potential of malignancy and GIST. Thus, gastric SET of patients≥60 years in age, and size≥25 mm should be evaluated thoroughly, and further therapeutic modalities such as endoscopic resection or surgery will be considered. There were some limitations in our study including: The sample size of enrolled patients was too small; it was the study conducted at only a single institute; medical records were not sufficiently accurate. Some reports showed that the malignant findings in the diagnostic images that suggest the consideration of the operation of gastric SET were mucosal ulceration, irregular margins, or rapid growth found in EGD; necrosis, hemorrhage, irregularity of margins, or abundant blood flow found in CT; heterogenecity, or irregular margins found in EUS. 16 However, detailed assessments of diagnostic images were also insufficient in our medical records. Further evaluation and larger-sized study are needed to assess the clinical risk factors for considering the surgery on upper gastrointestinal SET.
In conclusion, further evaluation and treatment of gastric SET are recommended for patients with subepithelial lesion in old age in order to eliminate the potential of malignancy. Furthermore, large size of subepithelial tumor as well as old age patients should be assessed carefully, considering potential of GIST. Exclusively, according to subgroup analysis, age≥60 and size≥25 mm in gastric SET may become an indicator for differential diagnosis of malignant gastric SET. Further studies concerning the malignant risk factors for gastric SET will be needed.
